2026-05-14 – Press Releases – www.prnewswire.com
– Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study – Japan Phase 3 results strengthen CARTISTEM’s® global commercial prospects, with Japan biologics license application (BLA) scheduled for 2H 2026 SEOUL, South…
